Literature DB >> 28595294

Coccidioidomycosis: An underreported cause of death-Arizona, 2008-2013.

Jefferson M Jones1, Lia Koski2, Mohammed Khan3, Shane Brady4, Rebecca Sunenshine5, Ken K Komatsu4.   

Abstract

In Arizona during 1997-2013, coccidioidomycosis increased from 21 to 90 cases/100,000 population, but coccidioidomycosis-associated deaths remained stable at 3-6 deaths/million population. We used the capture-recapture method by using death certificates and hospital discharge data to more fully estimate the total number of coccidioidomycosis-attributable deaths and compared this with published estimates. Death certificates were included if any cause of death included coccidioidomycosis; hospital discharge data deaths were included if any discharge diagnosis included coccidioidomycosis and laboratory confirmation. Among deaths during 2008-2013, we identified 529 coccidioidomycosis-attributable deaths from death certificates and 560 from hospital discharge data, with 251 deaths identified in both databases. Capture-recapture estimated 1,178 total coccidioidomycosis-attributable deaths, compared with 164 deaths (underlying cause of death) or 529 deaths (any cause of death) on death certificates. Coccidioidomycosis-attributable deaths are underreported from two- to sevenfold on Arizona death certificates, demonstrating an education need for death certifiers to document coccidioidomycosis mortality. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology 2017.

Entities:  

Keywords:  capture-recapture; cause of death; coccidioidomycosis; epidemiology; surveillance

Mesh:

Year:  2018        PMID: 28595294      PMCID: PMC6080208          DOI: 10.1093/mmy/myx041

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  28 in total

1.  Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics.

Authors:  L A Johansson; R Westerling
Journal:  Int J Epidemiol       Date:  2000-06       Impact factor: 7.196

2.  Death certificate completion: how well are physicians trained and are cardiovascular causes overstated?

Authors:  Dhanunjaya R Lakkireddy; Manohar S Gowda; Caroline W Murray; Krishnamohan R Basarakodu; James L Vacek
Journal:  Am J Med       Date:  2004-10-01       Impact factor: 4.965

3.  Improving the accuracy of death certification.

Authors:  K A Myers; D R Farquhar
Journal:  CMAJ       Date:  1998-05-19       Impact factor: 8.262

Review 4.  The impact of under and over-recording of cancer on death certificates in a competing risks analysis: a simulation study.

Authors:  Sally R Hinchliffe; Keith R Abrams; Paul C Lambert
Journal:  Cancer Epidemiol       Date:  2012-09-20       Impact factor: 2.984

Review 5.  Coccidioidomycosis: Recent Updates.

Authors:  Meryl Twarog; George R Thompson
Journal:  Semin Respir Crit Care Med       Date:  2015-09-23       Impact factor: 3.119

6.  Overreporting of deaths from coronary heart disease in New York City hospitals, 2003.

Authors:  Reena Agarwal; Jennifer M Norton; Kevin Konty; Regina Zimmerman; Maleeka Glover; Akaki Lekiachvili; Henraya McGruder; Ann Malarcher; Michele Casper; George A Mensah; Lorna Thorpe
Journal:  Prev Chronic Dis       Date:  2010-04-15       Impact factor: 2.830

7.  Validation of death certificate diagnosis for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  S A Coady; P D Sorlie; L S Cooper; A R Folsom; W D Rosamond; D E Conwill
Journal:  J Clin Epidemiol       Date:  2001-01       Impact factor: 6.437

8.  Effect of cause-of-death training on agreement between hospital discharge diagnoses and cause of death reported, inpatient hospital deaths, New York City, 2008-2010.

Authors:  Paulina Ong; Melissa Gambatese; Elizabeth Begier; Regina Zimmerman; Antonio Soto; Ann Madsen
Journal:  Prev Chronic Dis       Date:  2015-01-15       Impact factor: 2.830

9.  Coccidioidomycosis-associated Deaths, United States, 1990-2008.

Authors:  Jennifer Y Huang; Benjamin Bristow; Shira Shafir; Frank Sorvillo
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

10.  Guillain-Barré syndrome surveillance during National Influenza Vaccination Campaign, New York, U.S.A., 2009.

Authors:  Gregory P Giambrone; Shelley M Zansky; Millicent Eidson; Pamela G Duncan; Louise-Anne McNutt; Guthrie S Birkhead
Journal:  Emerg Infect Dis       Date:  2013-12       Impact factor: 6.883

View more
  5 in total

Review 1.  Update on the Epidemiology of coccidioidomycosis in the United States.

Authors:  Orion Z McCotter; Kaitlin Benedict; David M Engelthaler; Ken Komatsu; Kimberley D Lucas; Janet C Mohle-Boetani; Hanna Oltean; Duc Vugia; Tom M Chiller; Gail L Sondermeyer Cooksey; Alyssa Nguyen; Chandler C Roe; Charlotte Wheeler; Rebecca Sunenshine
Journal:  Med Mycol       Date:  2019-02-01       Impact factor: 4.076

2.  Economic Burden of Fungal Diseases in the United States.

Authors:  Kaitlin Benedict; Hilary K Whitham; Brendan R Jackson
Journal:  Open Forum Infect Dis       Date:  2022-03-23       Impact factor: 3.835

3.  Delays in Coccidioidomycosis Diagnosis and Associated Healthcare Utilization, Tucson, Arizona, USA.

Authors:  Fariba M Donovan; Patrick Wightman; Yue Zong; Luke Gabe; Aneela Majeed; Tiffany Ynosencio; Edward J Bedrick; John N Galgiani
Journal:  Emerg Infect Dis       Date:  2019-09       Impact factor: 6.883

4.  Expansion of Coccidioidomycosis Endemic Regions in the United States in Response to Climate Change.

Authors:  Morgan E Gorris; Kathleen K Treseder; Charles S Zender; James T Randerson
Journal:  Geohealth       Date:  2019-10-10

5.  Δcps1 vaccine protects dogs against experimentally induced coccidioidomycosis.

Authors:  Lisa F Shubitz; Edward J Robb; Daniel A Powell; Richard A Bowen; Angela Bosco-Lauth; Airn Hartwig; Stephanie M Porter; Hien Trinh; Hilary Moale; Helle Bielefeldt-Ohmann; James Hoskinson; Marc J Orbach; Jeffrey A Frelinger; John N Galgiani
Journal:  Vaccine       Date:  2021-10-23       Impact factor: 4.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.